WVE vs. AXSM, TLX, BPMC, GRFS, NUVL, KRYS, VRNA, CYTK, ELAN, and PTCT
Should you be buying Wave Life Sciences stock or one of its competitors? The main competitors of Wave Life Sciences include Axsome Therapeutics (AXSM), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Blueprint Medicines (BPMC), Grifols (GRFS), Nuvalent (NUVL), Krystal Biotech (KRYS), Verona Pharma (VRNA), Cytokinetics (CYTK), Elanco Animal Health (ELAN), and PTC Therapeutics (PTCT). These companies are all part of the "pharmaceutical products" industry.
Wave Life Sciences vs.
Axsome Therapeutics (NASDAQ:AXSM) and Wave Life Sciences (NASDAQ:WVE) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, community ranking, media sentiment, earnings, dividends and risk.
Axsome Therapeutics has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, Wave Life Sciences has a beta of -1.04, meaning that its stock price is 204% less volatile than the S&P 500.
Wave Life Sciences has lower revenue, but higher earnings than Axsome Therapeutics. Axsome Therapeutics is trading at a lower price-to-earnings ratio than Wave Life Sciences, indicating that it is currently the more affordable of the two stocks.
Wave Life Sciences has a net margin of -66.50% compared to Axsome Therapeutics' net margin of -74.47%. Axsome Therapeutics' return on equity of -223.51% beat Wave Life Sciences' return on equity.
Axsome Therapeutics received 110 more outperform votes than Wave Life Sciences when rated by MarketBeat users. Likewise, 70.41% of users gave Axsome Therapeutics an outperform vote while only 67.78% of users gave Wave Life Sciences an outperform vote.
In the previous week, Wave Life Sciences had 8 more articles in the media than Axsome Therapeutics. MarketBeat recorded 21 mentions for Wave Life Sciences and 13 mentions for Axsome Therapeutics. Axsome Therapeutics' average media sentiment score of 0.85 beat Wave Life Sciences' score of 0.83 indicating that Axsome Therapeutics is being referred to more favorably in the media.
81.5% of Axsome Therapeutics shares are owned by institutional investors. Comparatively, 89.7% of Wave Life Sciences shares are owned by institutional investors. 22.4% of Axsome Therapeutics shares are owned by company insiders. Comparatively, 29.1% of Wave Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Axsome Therapeutics currently has a consensus price target of $167.64, suggesting a potential upside of 37.67%. Wave Life Sciences has a consensus price target of $22.60, suggesting a potential upside of 150.83%. Given Wave Life Sciences' higher possible upside, analysts clearly believe Wave Life Sciences is more favorable than Axsome Therapeutics.
Summary
Axsome Therapeutics and Wave Life Sciences tied by winning 9 of the 18 factors compared between the two stocks.
Get Wave Life Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Wave Life Sciences Competitors List
Related Companies and Tools
This page (NASDAQ:WVE) was last updated on 3/28/2025 by MarketBeat.com Staff
Buy WVE Stock Free WVE Stock Alerts